Portage Biotech

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31 2023-09-30
Revenue
$0
$0
$0
$0
Gross Profit
-8
-15
-14
EBITDA
-2,839
-4,025
-5,917
EBIT
-2,847
-4,040
-5,932
Net Income
-1,656
-24,889
-39,373
-5,158
Net Change In Cash
0
0
0
0
Free Cash Flow
-1,686
-3,121
-3,334
-4,297
Cash
3,334
5,028
5,341
3,445
Basic Shares
1,049
989
20,897
17,801

Annual Financials

Values in thousands 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Revenue
$0
$0
$0
$0
Gross Profit
-54
-1
EBITDA
-18,199
-16,618
-15,650
-14,186
EBIT
-18,253
-16,619
-31,238
-26,426
Net Income
-75,339
-104,611
-19,169
-17,189
Net Change In Cash
0
0
0
0
Free Cash Flow
-14,297
-12,076
-6,764
-3,283
Cash
5,028
10,545
23,352
2,770
Basic Shares
20,340
16,119
13,060
11,733

Earnings Calls

Quarter EPS
2024-06-30
-$1.25
2024-03-31
$0
2023-12-31
$0.01
2023-09-30
-$0.29